Replies to post #509997 on NorthWest Biotherapeutics Inc (NWBO)

[Bob_LobLaw]

The longer this goes, the more disappointing a no news walk through will be. They are fully committed to waiting for significant news before announcing ASM which is why I think there is a really good chance we do not have an ASM in 2022. Yes I know they said we would have one this year but it’s not like they have any credibility to hang their hat on.

[Poor Man -]

Horse, I agree. The need for this journal article does make it look like a condition precedent for some type of financial agreement. Is it something that a partner would like in order to show their investment analysts, or does LP have such a big ask in the proxy that she feels the JA would make for a good justification?

The problem with the delay is it places the company in suspended animation, while shareholders continue to be diluted. LP should try to find a work around.

[biosectinvestor]

I agree, and I expect they will have an ASM as well. I think they know exactly what they are waiting on and a general range of time, but it took a while to get to that relative clarity, I expect, as well.